Introduction
Increasing use of arterial grafts as conduits for coronary artery bypass surgery has led to recognition of a shortterm complication characterized by low flow in the coronary vasculature distal to the graft and poor myocardial perfusion [1] [2] [3] [4] . To treat the syndrome, systemic administration of inotropes such as adrenaline may be used to maintain cardiac output. This may further compromise myocardial perfusion and may thus precipitate heart failure or myocardial infarction. This low-flow syndrome usually occurs during the initial 48 h after surgery, has been reported with internal mammary artery grafts as well as radial artery grafts [1, 2] and is common. Acar et al. reported thread-like vessels on angiography in 4% of artery grafts, suggesting marked vasoconstriction [3] . Other groups, using less stringent clinical criteria, have suggested that this hypoperfusion syndrome may occur in up to 10% of cases [4] . A wide range of different approaches are in current use to try to limit the development of this clinically important syndrome, including in vitro pre-incubation of the graft with vasodilators such as the phosphodiesterase G inhibitor papaverine.
An important candidate mediator of the syndrome is increased alpha-adrenoceptor pathway activation. Although pre-incubation with papaverine is used in several major centres in Europe and in the U.S.A., it is short-acting and effects of pre-incubation of grafts with papaverine on alpha-1 adrenoceptor activation are not clear. The expected constriction was prevented when epinephrine was added to radial arteries immediately after they had been incubated for 60 min with a high concentration (1 mg.ml 1 ) of the alpha-adrenoceptor blocker phenoxybenzamine [5] . A 1-h incubation period is not clinically practical for coronary bypass surgery. We studied the effects of a brief 20-min pre-incubation of radial arteries with a lower, clinically appropriate concentration of phenoxybenzamine on catecholamineinduced vasoconstriction. We compared the efficacy and duration of these effects to those of pre-incubation with papaverine.
Methods
We studied 12 patients undergoing elective coronary artery bypass. Eleven were men, mean age 64 (range 53-74) years and three had diabetes mellitus. As expected in these patients with multiple cardiovascular risk factors and established coronary artery disease, treatment included statins, aspirin, nitrates, ACE inhibitors, calcium channel blockers, beta-blockers, diuretics and antidiabetic drugs. Direct effects of previous oral drug treatment were minimized by careful washing of the segments and by constant perfusion of vascular rings throughout the experiments (see below). The study was approved by the local hospital ethics committee.
We studied segments of radial arteries harvested at the time of bypass. Radial arteries were harvested from the mid-forearm. Vascular rings were obtained for in vitro studies randomly from proximal and distal ends of the harvested artery. Within each in vitro experiment, rings from the same section of radial artery were used for active treatment and as controls. The above protocol minimized any possible confounding effects of regional differences in receptor densities for out findings. Ex vivo, the artery segments were not exposed to any exogenous vasodilators prior to collection. The arteries were removed with adjacent veins and surrounding subcutaneous fat and were placed in ice-cold physiological saline solution. The vessels were dissected free of adnexa in icecold psychological saline solution under magnification within 60 min of harvesting. Five-millimetre ring segments of vessel were cut and mounted on a classical organ bath. Two to four segments were taken from each vessel.
The organ bath techniques were as previously reported [6] and are described here in brief. Arterial segments were mounted on two stainless steel stirrups placed through the lumen of the vessels. The upper stirrup was attached to a force transducer. The tension to which the vessels were subjected was increased manually in increments of 1 g across the range from 1 g to 7 g over 30 min to achieve the maximum active tension for the minimum resting tension. From previous length tension experiments [6] this allows approximation to a circumference of 90% of the internal circumference of the artery at a transmural pressure of 100 mmHg. Rings were then allowed to equilibrate for a further 60 min at this tension. During all incubations of greater than 20 min, vessels were washed at a rate of 1 ml . min 1 with oxygenated psychological saline solution at 37 C. Following equilibration, arterial segments were contracted with psychological saline solution containing 124 m potassium to obtain maximum smooth muscle contraction. The contractions were repeated three times or until the tension achieved in two consecutive contractions was within 10%. The vessels were washed and allowed to equilibrate after contraction. For all vascular rings, constrictor concentration response curves were then obtained by adding increasing concentrations of norepinephrine to the organ bath in half-log molar incremental doses at 2-min intervals to give final concentrations from 10 8  (2 ng.ml 1 ) to 10 5  (2 g.ml 1 ). The vessels were then washed and pre-constricted with 10 6  norepinephrine. This concentration of norepinephrine in these studies gave a contraction that was 80% of maximal. Once the contraction had reached a stable plateau, in order to assess the endothelial integrity of the vessels, increasing concentrations of acetylcholine were added to the organ bath in incremental doses to give final concentrations of . At the end of the incubation a further norepinephrine concentration curve was constructed. The vessels were then washed and norepinephrine concentration responses were repeated at 2, 4 and 18 h post-washout of the pre-treatment agent in the phenoxybenzamine treated vessels and after 2, 4, 8, 18 h in the papaverine-treated vessels. To assess contractile viability of the arterial segments at the end of the 18 h of incubation, all vessels were constricted with 124 m potassium solution and the thromboxane A 2 agonist U46619 (at a final concentration of 10 6 ).
Solutions and drugs
The physiological saline solution was buffered to pH 7·4, maintained at 37 C and bubbled with 5% CO 2 , 95% O 2 and consisted of m: NaCl 119, NaHCO 3 
Data analysis
Changes in isometric tension of the vessels were recorded on a personal computer using the MacLab/4e system (AD Instruments, Hastings, U.K.). Absolute maximum contraction to 124 m potassium solution was recorded as g.mm 1 of arterial segment. Force generated by the addition of constrictor agonists was expressed as a percentage of the absolute maximum force. Relaxation to endothelium-dependent relaxing factors was expressed as a percentage of the maximum pre-constriction tension.
Statistical significance
The data were reported as mean SEM. In all experiments the number quoted is for the number of patients from whom radial arteries were collected. Data were evaluated for statistical significance using two-way ANOVA for repeated measures. A probability of less than 0·05 (P<0·05) was considered statistically significant. Least significant difference values derived from the ANOVA were used when comparing individual data points.
Results

Initial contraction to norepinephrine
Prior to treatment all vessels showed concentrationdependent contraction to increasing incremental half-log molar doses of norepinephrine from 10 8 to 10 5 . No differences were seen in the sensitivities to norepinephrine between the vessels subsequently incubated with papaverine or phenoxybenzamine compared with control vessels in respective experiments.
Effects of pre-incubation for 20 min in papaverine
The addition of 3 10 3  papaverine had no effect on the resting tone of the radial artery segments. However at the end of 20 min of incubation in papaverine, the contractile response to norepinephrine was abolished (ANOVA P=0·019 treated vs control vessels: Fig. 1 ). This complete inhibition of constriction remained for 2 h after wash-out of papaverine. By 4 h after pretreatment with papaverine, the contraction to 10 5  norepinephrine was 21 9% of control vessels (Fig. 1) . By 8 h after pre-incubation with papaverine, there was markedly reduced inhibition of the contractile response to norepinephrine (vs control vessels P=0·319, ANOVA; Fig. 1 ). At 18 h after pre-treatment with papaverine, there was no residual difference in norepinephrineinduced constriction between pre-treated and control vessels (Fig. 1) .
Effects of pre-incubation for 20 min in phenoxybenzamine
The addition of 10 6  phenoxybenzamine had no effect on the resting tone of the radial artery segments. However, at the end of 20 min of incubation in phenoxybenzamine 10 6 , the contractile response to norepinephrine was abolished (treated vs control vessels P=0·001, ANOVA: Fig. 2 ). Constriction to the entire concentration range of norepinephrine studied was inhibited for at least 18 h after pre-treatment with phenoxybenzamine (pre-treated vs control vessels: P<0·0001, ANOVA; Fig. 2 ).
Vessel viability
Contractile responses
The radial artery preparations showed a mean absolute contraction to 124 m potassium solution of 6·16 0·37 g prior to treatment. There was no statistical difference between maximum contractions seen at the start of the experiments for arteries used for incubation with papaverine or phenoxybenzamine (6·27 0·59 g) vs control arteries (5·69 0·49 g; P=0·09). When vessels were re-studied 18 h after pre-treatment with either phenoxybenzamine, papaverine or control (psychological saline solution) there was no statistical difference in contractile responses versus control vessels within either treatment group on challenge with 124 m potassium chloride (KCl: pre-treated vessels 5·40 0·50 g vs control 5·40 0·57 g P=0·95) or the thromboxane A 2 agonist U46619 (U46619: pre-treated vessels 5·58 0·67 g versus control 5·79 0·53, P=0·73; Fig. 3 .
Endothelium-dependent relaxation
The response to the endothelium-dependent relaxing factor acetylcholine was tested prior to treatment and no significant difference was seen between control and treatment groups (phenoxybenzamine treated versus control P=0·70, papaverine treated versus control P=0·53, ANOVA). Maximum relaxation in response to 10 5  acetylcholine for papaverine-treated arteries was 56% versus 66% for control arteries and 83% for phenoxybenzamine-treated arteries versus 71% for control arteries. Two vessels in the papaverine group failed to relax by more than 50% of the pre-constricting tension. The exclusion from the analysis of these vessels did not alter the outcome of the experiments.
Discussion
The ideal agent for prevention of radial artery spasm has been the subject of several recent investigations because of renewed current interest in this vessel as an alternative
Vasodilator pre-treatment of human radial arteries 2211 conduit for coronary bypass surgery. We have shown for the first time that brief pre-treatment with the alphaadrenergic antagonist phenoxybenzamine prevents contraction for at least 18 h when the human radial artery is challenged with norepinephrine. In contrast, the protective effects of papaverine were relatively short-lived. Our findings could be important in providing an additional new approach to prevention of the hypoperfusion syndrome early after coronary artery bypass surgery, in particular because of the well-recognized increase in circulating levels of catecholamines during and after cardiopulmonary bypass.
Saphenous veins grafts were commonly used as conduits following the introduction of coronary artery bypass graft (CABG) surgery in the early 1960s [7] [8] [9] . Several groups went on to note increased early and late patency of arteries such as the internal mammary compared with saphenous vein as graft conduits [10, 11] . Cameron et al. [12] reported that 15 years after CABG surgery, two-thirds of their patients receiving a single internal mammary artery remained free of myocardial infarction compared with only half in the saphenous vein group. Mean survival was also better in the arterial conduit patients [12] . A wide range of other arteries are also now in regular use as bypass conduits including the gastro-epiploic, inferior epigastric and radial artery [13] . Initial results with the radial artery in the early 1970s were poor, with a high proportion of early post-operative graft occlusion when assessed angiographically [14] . Since then, better harvesting, 
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handling and surgical techniques have significantly improved short-term angiographic patency of radial artery grafts [15] . The widespread current use of radial and other arterial conduits for CABG has led to the recognition of a low-flow syndrome early after CABG [1] [2] [3] [4] . Mechanisms for the syndrome are unclear; however, increased levels of a wide range of vasoconstrictor mediators have been reported in the peri-operative period in association with CABG surgery, including angiotensin II, catecholamines, endothelin-1 and thromboxane A 2 [16] . There are two major reasons why this syndrome may be particularly likely to occur with the radial artery as a conduit for CABG. First, Chester et al. reported from in vitro studies that radial arteries show significantly greater reactivity to vasoconstriction in vitro compared with the internal mammary artery or saphenous vein, using angiotensin II as the agonist [17] . Second, for intrathoracic and upper abdominal arterial CABG conduits, the neural supply is preserved; however, the radial artery is denervated when used as a bypass graft. This is relevant to greater reactivity because it has been shown experimentally that denervation may result in increased expression of alpha-adrenoceptors [18] which would potentiate vasoconstriction in response to alphaadrenoceptor agonists.
Several empirical strategies have been used to try to prevent this syndrome. In many centres, a solution of papaverine, a phosphodiesterase G inhibitor with some calcium channel blocking actions, is used to pre-treat and distend the conduit artery prior to grafting [19] . Cooper et al. studied pre-treatment of internal mammary artery pedicles in situ with nifedipine, papaverine, glyceryltrinitate, sodium nitroprusside or saline prebypass surgery. Flow increased by 72% with papaverine, by around 200% with nifedipine or glyceryltrinitate and 250% with sodium nitroprusside. However, only acute relaxant effects on basal tone were studied and the ability of these agents to antagonize exogenous constrictor agonists was not assessed [19] . Recently, nitroglycerin in combination with calcium channel blockers such as verapamil or diltiazem has also been used for preincubation or systemic administration [20, 21] . He and Yang reported inhibition of constriction to 100 m potassium solution in radial arteries pre-treated with verapamil and nitroglycerin and studied 24 h later.
However, the ability of these agents to inhibit receptor-mediated constriction was not tested and baseline function in the stored vascular rings was not established. Furthermore these arteries had been stored at 4 C in a refrigerator [20] . Thus the duration of action of these agents may have been artificially prolonged and the possible benefits of pre-treatment overstated, as in some vessels relaxation may have reflected poor basal function. Our studies are more reflective of the clinical setting, in that our pre-treated vascular rings were perfused at 37 C throughout the 18 h of each experiment. In addition, we obtained serial assessment of vascular rings in all control and treated vessels.
Shapira et al. tested approaches to reversing established radial spasm using an in vitro model. They compared relaxant effects of nitroglycerin with diltiazem in radial artery segments constricted with the thomboxane mimetic U46619 in vitro. The calcium antagonist diltiazem was ineffective, whereas nitroglycerin increased the radial artery diameter by 22% [21] . This supports the use of nitroglycerin to treat established thromboxane-mediated radial spasm. However He and Yang provide a cautionary note, finding that radial arteries pre-treated with nitroglycerin developed tolerance to the subsequent administration of the drug [22] . Relaxation to the alternative nitric oxide donor sodium nitroprusside was not limited by tolerance [22] ; however, its clinical use is complicated by the potential accumulation of cyanide in the circulation [23] . The response to calcium channel blockers has been inconsistent. Cable et al. [24] , in an important study exploring both conventional pharmacology and gene therapy, reported no significant inhibition of norepinephrine-induced contraction by pre-treatment with diltiazem or verapamil, but found relaxation of norepinephrine-mediated contraction by pre-treatment with the short-acting dihydropyridine calcium antagonist nifedipine. In that study, pre-treatment with either of the nitric oxide donors, isosorbide dinitrate or nitroglycerin, inhibited contraction to norepinephrine and to KCl. The duration of protection from these constrictor agents by pre-treatment of radial arteries with these relaxing agents was not assessed. As noted above, a potential limitation of sustained administration of nitrates is tolerance, in addition to the potential haemodynamic side-effects of prolonged nitrate treatment.
Cable et al. also demonstrated both expression of eNOS and functional effects in radial artery segments with improved relaxation to KCl and to prostaglandin F 2a [24] . Of interest, expression was confirmed after 40 h of incubation, beyond the usual timeframe for the early radial artery vasospasm, but clearly of great potential interest for longer term prophylaxis.
Several lines of evidence support activation of the alpha-adrenoceptor pathway as an important candidate mediator of the hypoperfusion syndrome. Anaesthesia, hypothermia and circulatory arrest on cardiopulmonary bypass result in increases in the circulating levels of epinephrine and norepinephrine. Endogenous levels of catecholamines are around 3-4-fold increased in association with cardiopulmonary bypass [25] with around 20-fold higher levels resulting from deep hypothermia and circulatory arrest [26] . These raised levels persist for around 24 h. Furthermore, exogenous catecholamines are commonly used peri-operatively for circulatory support after coronary artery bypass grafting. Exogenous inotropes with alpha-1 agonist effects, such as norepinephrine, and higher doses of dopamine may be used clinically in the immediate post-operative period to increase cardiac output. There is also, as noted above, experimental evidence for up-regulation of alpha-1 adrenoceptors in grafted vessels in response to denervation [18] . Our study clearly shows that pre-treatment of radial arteries with papaverine, although initially effective, is short-acting with little residual inhibition of norepinephrine-induced vasoconstriction 8 h after papaverine pre-treatment. In contrast, our study showed that phenoxybenzamine provided long-acting complete inhibition of norepinephrine-induced vasoconstriction for at least 18 h before treatment with the drug. This long duration of inhibition by phenoxybenzamine results from alkylation of alpha-adrenoceptors, leading to a long-lasting non-competitive block. When given systematically, duration of action of this effect in man is in excess of 48 h. Of interest, in view of the probable multifactorial aetiology of the low flow syndrome, is that phenoxybenzamine also inhibits vasoconstriction by other agonists, including that mediated by acetylcholine via muscarinic receptors [27] and serotonin-mediated constriction [28] . Moreover, the renin-angiotensin pathway may also be activated by coronary artery bypass and effects of angiotensin II include stimulation of sympathetic outflow [29] which, through spillover of norepinephrine from nerve endings, could contribute to the increased levels of circulating norepinephrine after CABG. Of possible relevance to the hypoperfusion syndrome is the report that phenoxybenzamine can prevent angina at rest in native coronary arteries [30] . This may result, in part, from inhibition by phenoxybenzamine of alpha-adrenoceptor activation by increased sympathetic outflow, but could also reflect inhibition of alpha-adrenoceptor activation by increased circulating levels of alpha-agonist catecholamines. Further studies are needed into the clinical importance of prevention of the low-flow syndrome, and of the potential of phenoxybenzamine to inhibit these other pathways.
In our experiments, we achieved a range of norepinephrine concentrations between 10 8 and 10 5 mol.l 1 (a concentration of 2 ng.ml 1 to 2 g.ml 1 in the organ bath). Ensinger found that plasma norepinephrine levels in healthy volunteers rose in a linear fashion with infusion rates, reaching 7·5 1·1 ng.ml 1 with infusion rates of 0·2 g.kg 1 min 1 [31] . The higher end of this range of infusion rates is not uncommonly required in patients on cardiac intensive care units. Thus we used concentrations of norepinephrine up to approximately threefold higher than would be expected in vivo. We therefore believe that our model was clinically relevant in demonstrating inhibition of contraction to concentrations of norepinephrine that would occur in practice.
In our study, we used a phenoxybenzamine incubation solution at a concentration of 38 g.ml 1 . The arteries were then washed free of unbound phenoxybenzamine. The recommended therapeutic dose for phenoxybenzamine is 1 mg.kg 1 in 200 ml of physiological saline administered intravenously over 2 h (British National Formulary, September 1999), i.e. a 350 g.ml 1 solution infused systematically for a 70 kg patient. We would therefore expect no significant systematic effects in patients from our protocol for in vitro incubation of the radial artery with phenoxybenzamine.
A potential criticism of our study could be that the phenoxybenzamine in the organ bath destroyed the contractile apparatus of the vessel. However, as noted above, the concentration of phenoxybenzamine we used was one-tenth of that to which vessels are exposed at the site of infusion when the drug is used clinically. Furthermore, we showed that at a time 18 h after incubation with phenoxybenzamine when the response to norepinephrine remained completely abolished, two other contractile agonists (potassium and U46619) still brought about a contraction of a similar magnitude to that provoked prior to exposure of the arteries to phenoxybenzamine.
Patients undergoing coronary artery bypass graft surgery with a radial artery conduit commonly develop an early hypoperfusion syndrome which may be complicated by an early low cardiac output state [1] [2] [3] [4] . Administration of high doses of exogenous inotropes may further enhance the propensity to conduit spasm. Our in vitro study suggests that a clinically feasible brief 20-min pre-incubation of the radial artery with a low concentration of phenoxybenzamine should be considered in future strategies aimed at preventing this syndrome. It is likely that alpha-adrenoceptor mediated contraction is one of several constrictor mechanisms. Effective prevention of spasm may need more than one relaxant agent. For example pre-treatment with phenoxybenzamine did not prevent contraction to either potassium chloride or a thromboxane agonist (U46619) applied 18 h later; however, neither did papaverine.
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Nonetheless, in view of the well-described increase in circulating levels of catecholamines around the time of cardiac bypass, the importance of alpha-adrenoceptor agonists should neither be ignored nor underestimated. An effective strategy for prevention of radial artery spasm should therefore include a vasodilator protocol sufficient for effective and prolonged inhibition of alphaadrenoceptor mediated contraction. The observation that phenoxybenzamine also blocks a range of other constrictor pathways supports its use in this setting. Our findings strongly supports the inclusion of phenoxybenzamine along with, for example, other specific inhibitors of important vasoconstrictor mediators, such as thromboxane A 2 antagonists [32] in future strategies aimed at preventing this important syndrome.
